Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imiquimod.

Suzanne M Garland1

  • 1Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Carlton, Victoria, Australia. suzanne.garland@wch.org.au

Current Opinion in Infectious Diseases
|May 8, 2003
PubMed
Summary
This summary is machine-generated.

Imiquimod cream effectively treats genital warts by stimulating the immune system. It shows promise for other viral skin infections and precancerous lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causative Human Papillomavirus (HPV) Genotypes of Anal Cancers in Australian Cisgender Women.

Journal of medical virology·2026
Same author

Clinicopathologic characteristics and predictors of treatment uptake among patients with cervical cancer managed at Jimma University Medical Center, Southwest Ethiopia.

BMC cancer·2026
Same author

Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.

BMC cancer·2026
Same author

Immunogenicity of HPV Vaccine in a High-Risk and Understudied Group: Female Sex Workers.

The Journal of infectious diseases·2026
Same author

Novel features of <i>Mycoplasma genitalium</i> genomes identified through Oxford Nanopore sequence analysis of isolates from Australia.

Microbial genomics·2026
Same author

Gut microbiota composition in preterm infants with and without necrotizing enterocolitis: a systematic review and narrative synthesis.

Access microbiology·2025
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Imiquimod is a topical immune response modifier approved for genital warts.
  • It belongs to the imidazoquinoline class, stimulating innate and acquired immunity.
  • Its mechanism involves cytokine induction, activating the host immune system against infections and tumors.

Purpose of the Study:

  • To review the efficacy and safety of imiquimod in treating various skin conditions.
  • To explore the potential of imiquimod and related compounds for future therapeutic applications.

Main Methods:

  • Clinical efficacy and safety data review.
  • Analysis of preliminary studies on imiquimod for various dermatological conditions.

Main Results:

Related Experiment Videos

  • Imiquimod 5% cream is effective and safe for treating human papillomavirus (HPV) infections like condylomata acuminata.
  • Preliminary data indicate efficacy against molluscum contagiosum, HPV-related dysplasias, and non-melanoma skin cancers.
  • Promising results observed in both immunocompetent and immunosuppressed patients.

Conclusions:

  • Imiquimod is a valuable treatment for specific viral skin conditions.
  • Further research into imiquimod and newer imidazoquinolines is warranted for broader clinical use.
  • Potential applications include treating other cutaneous/mucosal viral infections, dysplasias, neoplasia, and as vaccine adjuvants.